IMBDX, a liquid biopsy-based ultra-precision medical company, announced on the 28th that CEO Kim Tae-yu received a commendation from the Minister of Trade, Industry and Energy in recognition of his outstanding technological capabilities and successful global expansion achievements.


This recognition was awarded for the innovative advancement of cancer precision medicine technology and continuous export growth. The company explained that it served as an opportunity to once again prove IMBDX's global competitiveness.


IMBDX has developed a diverse range of precision medical products, including AlphaLiquid for cancer prognosis analysis and targeted therapy profiling, CancerDetect for post-surgical cancer recurrence monitoring, and CancerFind for multi-cancer early screening.


The company is securing a technological advantage in the healthcare and cancer diagnostics markets. Since launching its first product, AlphaLiquid 100, in 2021, IMBDX has rapidly entered overseas markets and achieved notable results. In the Taiwan market, it quickly gained market share by offering high performance and services at about 30% of the price compared to leading global competitors' products.


Building on the successful know-how of entering the Taiwan market, IMBDX established a branch office in Japan in the second half of this year. It is achieving rapid sales growth and strengthening its presence in the Japanese, Indian, and Southeast Asian markets.


CEO Kim Tae-yu said, "This is an official recognition that IMBDX's technological capabilities and global market strategy have been successful," adding, "We will continue to promote sales growth and network expansion by providing innovative precision medical technologies to cancer patients worldwide."


Based on technological innovation, IMBDX plans to set new standards for cancer diagnosis and treatment technologies and firmly establish a leading position in the global healthcare market.



IMBDX CEO Kim Taeyu Receives Minister of Trade, Industry and Energy Award View original image


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing